Every morning, Kevin Gosnell opened his eyes and realized he had another day. Another chance to move his goal forward. Another opportunity to bring people together. Another 24 hours to motivate, inspire, build and plan for a future that wouldn’t include him.
In May of 2015, this 47-year-old husband, father of three and small business owner, was diagnosed with an aggressive form of ALS. After realizing there was no cure, and little that doctors could do to even treat his devastating condition, Kevin made a brave decision. To dig deeper. Ask questions. And use the resources, team building skills and relationships he had cultivated as a small business owner to create a new business. One committed to bringing the best doctors, researchers, and care practitioners together. To raising funds to fuel their efforts. And in the end, to finding a cure for ALS.
ALS ONE is a partnership of world-leading ALS researchers, doctors, and care practitioners focused on finding treatments for ALS and novel approaches to improve care for those battling the disease now. The unprecedented linking of minds and resources from Massachusetts General Hospital (MGH), University of Massachusetts Medical School (UMMS), ALS Therapy Development Institute (ALS TDI), and Compassionate Care ALS (CCALS), is unique for its leadership in efficiency, dedication to innovative research, and commitment to increasing access to care and treatment.